Image Protect, Inc. Unveils Strategic Growth Vision with InterceptCS™ Cold Sore Prevention System
TL;DR
Image Protect's InterceptCS™ offers a unique advantage in the cold sore prevention market with its Health Canada-approved, non-drug thermal therapy device, targeting a $3.5 billion global market.
InterceptCS™ operates as a Class II Medical Device in Canada, using thermal therapy during the prodrome stage to prevent cold sores, with a strategic multi-channel sales approach.
InterceptCS™ provides a safe, non-drug alternative for cold sore prevention, improving quality of life for millions globally by addressing an underserved health need.
Discover InterceptCS™, a groundbreaking thermal therapy device that prevents cold sores before they start, now expanding globally through ecommerce and Amazon.
Found this article helpful?
Share it with your network and spread the knowledge!
Image Protect, Inc. (OTC: IMTL) has recently shared an update on its strategic growth vision and long-term revenue objectives, focusing on its flagship innovation, the InterceptCS™ Cold Sore Prevention System. This update comes after the launch of its wholly owned subsidiary, Global Wellness Products, and the introduction of InterceptCS™, a Class II Medical Device approved by Health Canada for the prevention of cold sores. The device is unique in its approach, targeting the prevention of cold sores during the prodrome stage, a niche yet significant market opportunity.
The global cold sore market presents a substantial opportunity, with estimates suggesting a $1.2 billion annual market in the United States, $150 million in Canada, and over $3.5 billion worldwide. Image Protect aims to tap into this demand through a multi-channel sales strategy, including direct-to-consumer ecommerce and partnerships with online marketplaces like Amazon, Walmart.com, and eBay. The company's long-term revenue goal is ambitious, targeting up to $100 million annually within the next five years, driven by device sales and recurring purchases of thermal activators.
To achieve these objectives, Global Wellness Products is implementing a comprehensive marketing strategy that includes social media campaigns, paid advertising, search engine marketing, and influencer outreach. The company is also focusing on product innovation, with plans to introduce a new multi-use thermal activator designed to reduce consumer costs and improve profit margins.
Frank Casella, CEO of Global Wellness Products, expressed optimism about the early response to InterceptCS™ and the company's strategic positioning. With a focus on sustainable growth and a recurring revenue model, Image Protect is laying the groundwork for InterceptCS™ to become a globally recognized brand in personal wellness. The company's efforts are supported by regulatory approval from Health Canada and a growing ecommerce infrastructure, positioning it well to address the needs of cold sore sufferers worldwide.
This strategic update underscores Image Protect's commitment to innovation and growth in the wellness technology space, with InterceptCS™ at the forefront of its efforts to provide effective, non-drug alternatives for health management. The company's forward-looking statements reflect its ambition to capture a significant share of the global cold sore market, though it cautions that these projections are not guarantees of future performance.
Curated from NewMediaWire
